AR-12286 fixed-dose combination

· Aerie Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AR-12286 fixed-dose combination, covering 2016-09-23 to 2016-09-23. Get the full timeline:

Most recent: Clinical Trial Update: AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure [Phase 2]